China Medicine’s board of directors is currently comprised of five members:

Senshan Yang, Chairman and Director.

Mr. Senshan Yang has been our Chief Executive Officer since February 8, 2006, and a Director since February 10, 2006. He has been Chairman and General Manager of Konzern since July 2000. Prior to that, Mr. Yang served as a Manager Associate for Guangdong Maoming Petroleum Corporation, a state-owned company, for nearly 20 years. Mr. Yang obtained his bachelor’s degree from South China University of Technology in 1981.

Minhua Liu. Executive Vice President and Director

Ms. Liu has been President since February 8, 2006, and a Director since February 10, 2006. She has been Vice General Manager of Konzern since July 2000. Prior to that, she was a herbalist doctor for China Military Science Qiming Research Center in Beijing, responsible for overseeing the health care of all staff of the research center. Ms. Liu obtained her bachelor’s degree from Beijing College of Traditional Chinese Medicine in 1992.

Robert Adler, Independent Director

Mr. Robert Adler has been a Director and member of the Audit Committee since May 9, 2006. He is a private investor. Mr. Adler has been an investment adviser with UBS Financial Services since 2002 and recently taught financial English for a semester at Shanghai University of Finance and Economics. From 2000 to 2002, Mr. Adler previously served as a Managing Director for ING Furman Selz Asset Management. His prior experience includes serving as Vice President and Senior Investment Officer of BHF Securities Corp and DG Bank, New York Branch and as Vice President of Kuhn, Loeb & Co. He obtained a B.A. degree from Swarthmore College and studied at NYU School of Business Administration. He is a member of the Institute of Chartered Financial Analysts and a member of the board of directors of SinoEnergy Holding Co., a manufacturer of stainless steel vessels for liquid and compressed natural gas, and of Precision Aerospace Components, Inc., a distributor of high-quality internally-threaded fasteners, or nuts, for the aerospace and military industries.

Dr. Rachel Gong, Independent Director

Dr. Rachel Gong has been Director, Chairman of the Audit Committee and member of the Compensation Committee since May 9, 2006. She is an investment principal of Morningside, an international investment group based in Hong Kong, and has served in that position since 2004. Prior to that, Dr. Gong served as an investment banker for RBC Capital Markets from 2001 to 2004 and a senior auditor for PricewaterhouseCoopers from 1999 to 2001. Dr. Gong obtained a Ph.D. in Medical Science (Biochemistry and Molecular Biology) from the University of South Florida College of Medicine and an MBA from the Johnson Graduate School of Management of Cornell University.

Dr. Yanfang Chen, Independent Director

Dr. Yanfang Chen has been a Director and a member of the Compensation Committee since May 9, 2006. He is currently an assistant professor in the Department of Pharmacology & Toxicology at Wright State University’s Boonshoft School of Medicine, where during the past five years he has been research associate, senior research associate and research assistant professor. Dr. Chen obtained a Ph.D. degree from Medical Science Center, Peking University in China in 1995 and worked for Guangdong Provincial People's Hospital from 1995 to 1999. Dr. Chen is a professional member of the American Heart Association and the American Stroke Association, and a member of the American Society for Pharmacology and Experimental Therapeutics. He has numerous publications in his field of research.

Committee Composition. China Medicine maintains an Audit and Compensation committee. Ms. Rachel Gong serves as the chairperson in the Audit Committee and member of the compensation committee; Mr. Robert Adler serves as the member of the Audit Committee; and Mr. Yanfang Chen serves as the member of Audit Committee.